Page last updated: 2024-11-06

mitomycin and Angiosarcoma

mitomycin has been researched along with Angiosarcoma in 2 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Research Excerpts

ExcerptRelevanceReference
"In all 63 patients were treated monthly with a combination of mitomycin, doxorubicin, and cisplatin, and 27 (43%) experienced objective regression of their advanced sarcomas during a 3-month trial."7.67Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomas. ( Creagan, ET; Edmonson, JH; Green, SJ; Long, HJ; Richardson, RL, 1985)
"In all 63 patients were treated monthly with a combination of mitomycin, doxorubicin, and cisplatin, and 27 (43%) experienced objective regression of their advanced sarcomas during a 3-month trial."3.67Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomas. ( Creagan, ET; Edmonson, JH; Green, SJ; Long, HJ; Richardson, RL, 1985)
"Hepatic angiosarcoma has two distinct presentations: multiple tumors and a solitary tumor."1.32Five years and 4 months of recurrence-free survival in hepatic angiosarcoma. ( Acarli, K; Bilge, O; Cevikbaş, U; Erkan, M; Ozden, I, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ozden, I1
Bilge, O1
Erkan, M1
Cevikbaş, U1
Acarli, K1
Edmonson, JH1
Long, HJ1
Richardson, RL1
Creagan, ET1
Green, SJ1

Other Studies

2 other studies available for mitomycin and Angiosarcoma

ArticleYear
Five years and 4 months of recurrence-free survival in hepatic angiosarcoma.
    Journal of hepato-biliary-pancreatic surgery, 2003, Volume: 10, Issue:3

    Topics: Antibiotics, Antineoplastic; Chemoembolization, Therapeutic; Contrast Media; Disease-Free Survival;

2003
Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomas.
    Cancer chemotherapy and pharmacology, 1985, Volume: 15, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Dru

1985